ELICIO THERAPEUTICS

elicio-therapeutics-logo

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer. It offers potent vaccines and immunotherapies that enable precise targeting and delivery of immunogens directly to the lymphatic system, substantially enhancing the body's own system of immune defenses. The company was founded in 2011 and is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Event #Website #More

ELICIO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics

Founded:
2011-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.elicio.com

Total Employee:
11+

Status:
Active

Contact:
(617)945-2077

Email Addresses:
[email protected]

Total Funding:
163.91 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Microsoft Exchange Online Office 365 Mail


Similar Organizations

recor-medical-logo

ReCor Medical

ReCor Medical has developed a unique therapeutic non-focused ultrasound system

recludix-pharma-logo

Recludix Pharma

Recludix pharma is a developing platform to treat cancer patients.

nimbus-therapeutics-logo

Nimbus Therapeutics

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.

neukio-biotherapeutics-logo

Neukio Biotherapeutics

Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.

vico-therapeutics-logo

Vico Therapeutics

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

vyne-therapeutics-logo

VYNE Therapeutics

VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.

mindsciences-logo

MindSciences

MindSciences develops and implements evidence-based mindfulness solutions that delight its customers.

mersana-therapeutics-logo

Mersana Therapeutics

Mersana Therapeutics develops a biodegradable polymer platform Fleximerยฎ which creates new and better medicines.

actinium-pharmaceuticals-logo

Actinium Pharmaceuticals

Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.

avivomed-logo

Avivomed

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

alchemab-therapeutics-logo

Alchemab Therapeutics

Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

aratana-therapeutics-logo

Aratana Therapeutics

Aratana Therapeutics develops innovative therapies for the animal health industry.

abcuro-logo

Abcuro

Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

accengen-therapeutics-logo

AccenGen Therapeutics

Early stage therapeutics developing novel first-in-class anti-inflammatory medications

endpoint-health-logo

Endpoint Health

Precision Immunology Therapies

elstar-therapeutics-logo

Elstar Therapeutics

Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.

everimmune-logo

EverImmune

EverImmune provides therapeutic tools related to cancer.

7-hills-pharma-logo

7 Hills Pharma

7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCโ„ข platform.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

tallac-therapeutics-logo

Tallac Therapeutics

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

tempo-therapeutics-logo

Tempo Therapeutics

Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.

unleash-immuno-oncolytics-logo

Unleash Immuno Oncolytics

Unleashing the immune response to treat cancer.

serenity-bioworks-logo

Serenity Bioworks

Developing therapeutics derived from cellular stress pathways.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

spinal-cord-therapeutics-gmbh-logo

Spinal Cord Therapeutics GmbH

Spinal Cord Therapeutics GmbH develops treatments for spinal cord injury.

dynomics-logo

Dynomics

Molecules to restore heart function.

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

domain-therapeutics-logo

Domain Therapeutics

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

hbo2-therapeutics-logo

HbO2 Therapeutics

HbO2 Therapeutics develops and manufactures oxygen carrying solutions.

iaso-therapeutics-logo

Iaso Therapeutics

Iaso Therapeutics develops vaccines to improve human health and cure diseases.

idm-pharma-logo

IDM Pharma

IDM develops immunotherapies for cancer

imtherapeutics-logo

IMTherapeutics

IM Therapeutics develops personalized immuno-therapeutic drugs.

inceptor-bio-logo

Inceptor Bio

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.

gitr-logo

GITR

GITR develops therapies to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.

go-therapeutics-logo

GO Therapeutics

A new generation of cancer immunotherapy promise to change the paradigm of cancer treatment.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

glyscend-logo

Glyscend

Glyscend develops a revolutionary approach to treating type 2 diabetes.

gracell-biotechnologies-logo

Gracell Biotechnologies

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

osmol-therapeutics-logo

Osmol Therapeutics

Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.

oncorus-logo

Oncorus

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

oxford-vacmedix-logo

โ€‹Oxford Vacmedix

Develop therapeutic agents for the treatment of cancer .

oncopep-logo

OncoPep

OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.

zylรถ-therapeutics-logo

Zylรถ Therapeutics

Zylรถ Therapeutics offers an innovative sustained-release drug-delivery system.

carrick-therapeutics-logo

Carrick Therapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

clade-therapeutics-logo

Clade Therapeutics

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

cyteir-therapeutics-logo

Cyteir Therapeutics

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

coda-biotherapeutics-logo

CODA Biotherapeutics

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.

click-therapeutics-logo

Click Therapeutics

Click Therapeutics delivers safe and effective digital treatments to patients in need.

panther-therapeutics-logo

PanTher Therapeutics

PanTher Therapeutics features treatment platform designed to enhance therapeutic response with minimal side effects.

phico-therapeutics-logo

Phico Therapeutics

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.


Current Advisors List

phillip-k-russele_image

Phillip K. Russele Advisory Board @ Elicio Therapeutics
Advisor

nir-hacohen_image

Nir Hacohen Board of Directors @ Elicio Therapeutics
Board_member

Current Employees Featured

darrell-irvine_image

Darrell Irvine
Darrell Irvine Co-Founder, SAB member @ Elicio Therapeutics
Co-Founder, SAB member
2012-01-01

robert-connelly_image

Robert Connelly
Robert Connelly CEO @ Elicio Therapeutics
CEO

james-moon_image

James Moon
James Moon Director @ Elicio Therapeutics
Director

daniel-geffken_image

Daniel Geffken
Daniel Geffken Interim Chief Financial Officer and Director @ Elicio Therapeutics
Interim Chief Financial Officer and Director
2014-04-01

peter-c-demuth_image

Peter C. DeMuth
Peter C. DeMuth Chief Scientific Officer @ Elicio Therapeutics
Chief Scientific Officer
2022-01-01

george-siber_image

George Siber
George Siber Director @ Elicio Therapeutics
Director

christopher-haqq_image

Christopher Haqq
Christopher Haqq Executive Vice President, Head of Research & Development @ Elicio Therapeutics
Executive Vice President, Head of Research & Development
2019-10-01

joy-seymour_image

Joy Seymour
Joy Seymour Vice President, Head of Regulatory Affairs @ Elicio Therapeutics
Vice President, Head of Regulatory Affairs
2022-04-01

Founder


darrell-irvine_image

Darrell Irvine

satish-jindal_image

Satish Jindal

Investors List

trend-investment-group_image

Trend Investment Group

Trend Investment Group investment in Series B - Elicio Therapeutics

livzon-pharmaceutical-group_image

Livzon Pharmaceutical Group

Livzon Pharmaceutical Group investment in Series B - Elicio Therapeutics

clal-biotechnology_image

Clal Biotechnology Industries

Clal Biotechnology Industries investment in Series B - Elicio Therapeutics

efung-capital_image

EFung Capital

EFung Capital investment in Series B - Elicio Therapeutics

thynk-capital-llc_image

Thynk Capital, LLC.

Thynk Capital, LLC. investment in Venture Round - Elicio Therapeutics

access-bridgegap-ventures_image

Access BridgeGap Ventures

Access BridgeGap Ventures investment in Venture Round - Elicio Therapeutics

Official Site Inspections

http://www.elicio.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K

  • Host name: elicio.tempurl.host
  • IP address: 45.76.164.42
  • Location: Matawan United States
  • Latitude: 40.4652
  • Longitude: -74.2307
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 07747

Loading ...

More informations about "Elicio Therapeutics" on Search Engine